About Us
Research Watch
स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छनेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकटFrontline Perspectives on Nursing Leadership in NepalProtecting the Smallest Lungs from the Hidden Grip of RSV in KathmanduThe Heavy Burden of Bullying on Student Wellbeing in NepalThe Emerging Landscape of Thyroid Health in Central NepalHow a Recent Western Nepal Study is Redefining Anemia DiagnosisHow H. Pylori is Impacting the Health of Karnali’s High-Altitude CommunitiesSweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s YouthHow Missing Checklists and Protocols are Costing Lives in Nepal’s ERsस्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छनेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकटFrontline Perspectives on Nursing Leadership in NepalProtecting the Smallest Lungs from the Hidden Grip of RSV in KathmanduThe Heavy Burden of Bullying on Student Wellbeing in NepalThe Emerging Landscape of Thyroid Health in Central NepalHow a Recent Western Nepal Study is Redefining Anemia DiagnosisHow H. Pylori is Impacting the Health of Karnali’s High-Altitude CommunitiesSweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s YouthHow Missing Checklists and Protocols are Costing Lives in Nepal’s ERs

Updated 2026 Japanese Diagnostic Criteria for Takayasu Arteritis.

Researchers

Hajime Yoshifuji, Haruhito A Uchida, Yasuhiro Onishi, Yoshia Miyawaki, Eisuke Amiya, Ryotaro Asano, Takuya Hashimoto, Tomonori Ishii, Jun Ishizaki, Shuichi Ito, Toru Iwahashi, Naomi Iwata, Takatoyo Kiko, Yasuhiro Maejima, Takako Miyamae, Hiroko Nagafuchi, Kunihiro Shigematsu, Tsuyoshi Shirai, Natsuka Umezawa, Takahiko Sugihara, Yoshiko Watanabe, Naoto Tamura, Yoshikazu Nakaoka

Abstract

Takayasu arteritis (TAK) is a chronic, refractory large-vessel vasculitis designated as a Designated Intractable Disease in Japan. The Japanese diagnostic criteria for TAK, last revised in 2017, have been updated to the 2026 version as part of the Japanese Circulation Society 2026 guidelines on the management of large vessel vasculitis, and are presented here in English for the first time. The revision was conducted through a 3-round modified Delphi process involving a panel of 21 experts, supplemented by email discussion and an in-person meeting. The updated criteria incorporate 3 major changes: new symptoms were added and a qualifying statement introduced in Section A; pulmonary artery involvement was elevated to a main criterion in Section B; and IgG<sub>4</sub>-related periaortitis, Cogan syndrome, and drug-induced aortitis were added in Section C. These updates reflect advances in imaging technology and international classification frameworks, with an emphasis on improving diagnostic sensitivity to reduce missed diagnoses.
Source: PubMed (PMID: 42649021)View Original on PubMed